ChromoGenics participates in Horizon 2020 Switch2Save project

Report this content

The Switch2save project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 869929. The total grant amount is 5 468 KEUR and out of this 1 035 KEUR will go to ChromoGenics. 

The aim of the Switch2Save project is to combine the most advanced electrochromic materials and thermochromic materials to manufacture lightweight, hybrid-enabled switchable optical systems. Another aim is to demonstrate long service life, energy saving potential and cost affordability both in installation and maintenance. The output will be smart insulated glass units with improved optical properties and reduced production costs. Large installations in an office building in Uppsala and a hospital in Athens will also be carried out within the project.  

“The consortium behind Switch2Save consists partly of actors such as architects, facade contractors and property managers and also end users. In addition, several of Europe's leading research institutes in electrochromism are included and we are really looking forward to developing the next generation of dynamic glass using both electrochromic and thermochromic technology” says CTO Greger Gregard. 


Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430

This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 23 September, 2019, at 22:30 CET.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Growth Market with G&W Fondkommission as Certified Adviser e-mail:, tel.: +46 (0) 8 503 000 50



Documents & Links